Published in Mol Pharm on April 18, 2012
Development and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosis. Drug Des Devel Ther (2015) 0.83
Pharmaceutical microparticle engineering with electrospraying: the role of mixed solvent systems in particle formation and characteristics. J Mater Sci Mater Med (2015) 0.82
Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterization. Drug Des Devel Ther (2017) 0.75
Functional bionetworks from nanoliter water droplets. J Am Chem Soc (2007) 1.81
Test of the Epstein-Plesset model for gas microparticle dissolution in aqueous media: effect of surface tension and gas undersaturation in solution. Langmuir (2004) 1.76
Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia (2006) 1.52
Hydration potential of lysozyme: protein dehydration using a single microparticle technique. Biophys J (2010) 1.47
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res (2012) 1.38
Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res (2006) 1.37
Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim Biophys Acta (2005) 1.36
Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer. Open Nanomed J (2011) 1.14
Polymeric drug delivery of platinum-based anticancer agents. J Pharm Sci (2009) 1.13
On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device. Lab Chip (2011) 1.09
Drug-eluting stents: factors governing local pharmacokinetics. Adv Drug Deliv Rev (2006) 1.08
Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours. Int J Hyperthermia (2010) 1.08
Microdroplet dissolution into a second-phase solvent using a micropipet technique: test of the Epstein-Plesset model for an aniline-water system. Langmuir (2006) 1.01
Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. Mol Pharm (2012) 0.97
The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate. J Mater Sci Mater Med (2010) 0.93
Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint. J Pharm Sci (2004) 0.91
A magnetically controlled MEMS device for drug delivery: design, fabrication, and testing. Lab Chip (2011) 0.91
In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators. Biomaterials (2008) 0.90
Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome. Int J Hyperthermia (2008) 0.90
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. J Control Release (2013) 0.90
Paclitaxel loaded poly(L-lactic acid) (PLLA) microspheres. II. The effect of processing parameters on microsphere morphology and drug release kinetics. Int J Pharm (2004) 0.89
Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques. Int J Hyperthermia (2008) 0.88
Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits. J Pharm Sci (2005) 0.88
The materials engineering of temperature-sensitive liposomes. Methods Enzymol (2004) 0.88
Disc formation in cholesterol-free liposomes during phase transition. Biochim Biophys Acta (2003) 0.87
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. Cancer Chemother Pharmacol (2005) 0.86
In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer. Clin Cancer Res (2011) 0.85
The use of tissue sealants to deliver antibiotics to an orthopaedic surgical site with a titanium implant. J Orthop Sci (2012) 0.84
Effects of continuous and pulsatile PTH treatments on rat bone marrow stromal cells. Biochem Biophys Res Commun (2009) 0.84
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer. Int J Hyperthermia (2014) 0.84
The effect of hydrogen bonding on the diffusion of water in n-alkanes and n-alcohols measured with a novel single microdroplet method. J Chem Phys (2010) 0.84
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer. BJU Int (2008) 0.84
An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics. J Biomed Mater Res A (2010) 0.83
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer. BJU Int (2008) 0.83
Hyperbranched polymers for controlled release of cisplatin. Dalton Trans (2008) 0.83
A preliminary report on the effects of paclitaxel-impregnated stents on sheep nasal mucosa. Am J Rhinol (2004) 0.83
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy. BJU Int (2008) 0.83
Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel. Int J Pharm (2004) 0.83
Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm Res (2002) 0.82
Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity. J Pharm Sci (2007) 0.82
PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections. Pharm Res (2009) 0.82
The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis (2005) 0.81
The differential in vitro and in vivo responses of bone marrow stromal cells on novel porous gelatin-alginate scaffolds. J Tissue Eng Regen Med (2009) 0.81
Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure. Ultrasonics (2011) 0.81
The use of nanocrystalline cellulose for the binding and controlled release of drugs. Int J Nanomedicine (2011) 0.80
The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance. Int J Nanomedicine (2013) 0.80
Determining the critical micelle concentration of a novel lipid-lowering agent, disodium ascorbyl phytostanyl phosphate (FM-VP4), using a fluorescence depolarization procedure. Drug Dev Ind Pharm (2004) 0.80
Clusterin antisense complexed with chitosan for controlled intratumoral delivery. Int J Pharm (2007) 0.80
P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity. Mol Pharm (2008) 0.80
The characterization of novel polymeric paste formulations for intratumoral delivery. Int J Pharm (2004) 0.79
A method to convert MRI images of temperature change into images of absolute temperature in solid tumours. Int J Hyperthermia (2013) 0.79
Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release. Int J Pharm (2004) 0.79
Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin. Biomacromolecules (2010) 0.79
In vitro and in vivo evaluation of intravesical docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols in an orthotopic model of bladder cancer. Biomacromolecules (2011) 0.78
The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors. Cancer Chemother Pharmacol (2007) 0.78
Evaluation of synthetic phospholipid ultrasound contrast agents. Ultrasonics (2002) 0.78
The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Int J Pharm (2007) 0.78
Use of fibrin sealants for the localized, controlled release of cefazolin. Can J Surg (2006) 0.78
Fabrication of robust hydrogel coatings on polydimethylsiloxane substrates using micropillar anchor structures with chemical surface modification. ACS Appl Mater Interfaces (2014) 0.78
Intra-articular treatment of inflammatory arthritis with microsphere formulations of methotrexate: pharmacokinetics and efficacy determination in antigen-induced arthritic rabbits. Inflamm Res (2009) 0.77
Increased accumulation and retention of micellar paclitaxel in drug-sensitive and P-glycoprotein-expressing cell lines following ultrasound exposure. Ultrasound Med Biol (2012) 0.77
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium. Biomaterials (2011) 0.77
Dynamics of neutrophil membrane compliance and microstructure probed with a micropipet-based piconewton force transducer. Ann Biomed Eng (2007) 0.77
New technology and clinical applications of nanomedicine: highlights of the second annual meeting of the American Academy of Nanomedicine (Part I). Nanomedicine (2006) 0.77
Enzyme dehydration using Microglassification™ preserves the protein's structure and function. J Pharm Sci (2014) 0.77
Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-alpha-induced apoptosis is mediated by the p38 MAP kinase. Cell Signal (2004) 0.77
Calcium pyrophosphate dihydrate crystal-induced inhibition of neutrophil apoptosis: involvement of Bcl-2 family members. Inflamm Res (2009) 0.77
Mixed molecular weight copolymer nanoparticles for the treatment of drug-resistant tumors: formulation development and cytotoxicity. J Pharm Sci (2014) 0.77
Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration. Int J Pharm (2011) 0.76
Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation. Anal Bioanal Chem (2014) 0.76
The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibiotics. J Mater Sci Mater Med (2012) 0.76
Mass transfer in the dissolution of a multicomponent liquid droplet in an immiscible liquid environment. Langmuir (2013) 0.75
Amphiphilic dextran-graft-poly(epsilon-caprolactone) films for the controlled release of paclitaxel. Int J Pharm (2004) 0.75
The solid-state characterization of fusidic acid. Int J Pharm (2011) 0.75
Unimolecular micelles based on hydrophobically derivatized hyperbranched polyglycerols: ligand binding properties. Biomacromolecules (2008) 0.75
Professional courtesy, please. Tex Med (2004) 0.75
Controlled release of alendronate from polymeric films. J Biomater Sci Polym Ed (2009) 0.75
Microglassification™: a novel technique for protein dehydration. J Pharm Sci (2014) 0.75
Governance: time to invite new talent to the table. Health Serv J (2013) 0.75
An Activity-Based Dissolution Model for Solute-Containing Microdroplets. Langmuir (2016) 0.75
The encapsulation of ribozymes in biodegradable polymeric matrices. Int J Pharm (2002) 0.75